Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors
Clinical trial NCT00594633 · COMPLETED
Trial details
- NCT number
- NCT00594633
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.